GeoVax Labs, Inc.
GOVX
$0.92
-$0.09-8.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 864.40K | 2.79M | 300.70K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 864.40K | 2.79M | 300.70K | -- | -- |
| Cost of Revenue | 7.61M | 7.40M | 4.28M | 4.43M | 6.23M |
| Gross Profit | -6.74M | -4.61M | -3.98M | -4.43M | -6.23M |
| SG&A Expenses | 1.60M | 1.24M | 1.09M | 1.46M | 1.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.21M | 8.64M | 5.36M | 5.88M | 7.69M |
| Operating Income | -8.34M | -5.85M | -5.06M | -5.88M | -7.69M |
| Income Before Tax | -8.26M | -5.82M | -5.06M | -5.85M | -7.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.26M | -5.82M | -5.06M | -5.85M | -7.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.26M | -5.82M | -5.06M | -5.85M | -7.59M |
| EBIT | -8.34M | -5.85M | -5.06M | -5.88M | -7.69M |
| EBITDA | -8.32M | -5.82M | -5.04M | -5.86M | -7.67M |
| EPS Basic | -0.86 | -0.91 | -1.99 | -2.47 | -3.83 |
| Normalized Basic EPS | -0.54 | -0.57 | -1.25 | -1.54 | -2.40 |
| EPS Diluted | -0.86 | -0.91 | -1.99 | -2.47 | -3.83 |
| Normalized Diluted EPS | -0.54 | -0.57 | -1.25 | -1.54 | -2.40 |
| Average Basic Shares Outstanding | 9.64M | 6.40M | 2.54M | 2.37M | 1.98M |
| Average Diluted Shares Outstanding | 9.64M | 6.40M | 2.54M | 2.37M | 1.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |